Decoding RNA Modifications in Cancer Biology
A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Cancer Biology".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 120
Special Issue Editor
Interests: RNA modifications; gene regulation; cancer biology
Special Issue Information
Dear Colleagues,
RNA modifications, such as N6-methyladenosine (m6A) and pseudouridine (Ψ), have emerged as key regulators of gene expression at the post-transcriptional level. These chemical markers dynamically modulate RNA stability, translation, splicing, and localization, thereby shaping fundamental processes in cell fate determination. In cancer biology, the dysregulation of RNA modification “writers”, “readers”, and “erasers” has been increasingly recognized as a driving force behind tumor initiation and progression.
This Special Issue, “Decoding RNA Modifications in Cancer Biology”, will highlight advances in understanding the molecular mechanisms behind RNA modifications in cancer, with an emphasis on how these epitranscriptomic modifications reprogram gene expression networks, influence tumor progression, and contribute to therapeutic resistance. We welcome original research articles and reviews that investigate mechanistic insights, advance high-throughput mapping technologies, dissect RNA modification-associated signaling pathways, and reveal their therapeutic potential in cancer biology.
By bringing together cutting-edge studies in epitranscriptomics and oncology, this Special Issue will inspire new perspectives and foster collaborations that will advance our knowledge of RNA biology in cancer.
Dr. Yutao Zhao
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RNA modifications
- epitranscriptomics
- gene regulation
- RNA biology
- post-transcriptional regulation
- N6-methyladenosine (m6A)
- pseudouridine (Ψ)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
